# Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

> **NCT04122287** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 250 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** tinidazole

## Key facts

- **NCT ID:** NCT04122287
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122287, "Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04122287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*